Every recall we track for Lupin Pharmaceuticals Inc. — 123 in all — plus the complaints and injury reports the public filed about them.
Lupin Pharmaceuticals recalls 0.05% Clobetasol Propionate Cream due to failed content uniformity. This may affect medication strength. Check NDC 68180-956-04 and lot numbers for affected products.
Lupin Pharmaceuticals recalls Glucagon Emergency Kits due to a CGMP deviation in stability testing. Affected kits have specific lot numbers and expiration dates. Consumers should contact the manufacturer for details.
Lupin Pharmaceuticals recalls prednisolone acetate ophthalmic suspension (1%) due to foreign substance presence. Rx-only medication with specific NDC codes and expiration dates affected.
Lupin Pharmaceuticals recalls Liraglutide injection with white thread-like particles that could cause injection site reactions. Affected lots expire through 2027. Stop using and contact for replacement.
Lupin Pharmaceuticals recalls Ganirelix Acetate injection due to impurities in the product. This may affect patients using the medication. Contact the manufacturer for details.
Lupin Pharmaceuticals recalls 100mg sertraline tablets with defective bottle seals that may not stay closed, risking medication exposure. Affected lots: QB00865, exp. Feb 2028.
Lupin Pharmaceuticals recalls 2.5mg/10mg capsules with wrong expiry date (Feb 2027 instead of Jan 2027). Discard or contact for replacement.
Lupin Pharmaceuticals recalls 25mg clomipramine capsules due to potential impurities from degradation. Affected lots may pose safety risks. Check NDC# 68180-492-01 and lot numbers for details.
Lupin Pharmaceuticals recalls 20mg/12.5mg lisinopril and hydrochlorothiazide tablets due to foreign tablets found in sealed bottles. This product is for prescription use only.
Lupin Pharmaceuticals recalls 25mg clomipramine capsules due to impurities detected in stability testing. This may cause serious health risks. Affected products have specific lot numbers and expiration dates.
Lupin recalls 75 mcg levothyroxine tablets due to impurity issues detected in drug substance during stability testing. Affected units may pose safety risks if not properly handled.
Lupin Pharmaceuticals recalls 5mg Ramipril capsules due to active pharmaceutical ingredient sourced from an unapproved vendor. Affected lots have specific NDC numbers and expiration dates.
Lupin Pharmaceuticals recalls 2.5mg Ramipril capsules due to active pharmaceutical ingredient sourced from an unapproved vendor. This may affect safety for users. Check NDC codes and expiration dates for affected lots.
Lupin Pharmaceuticals recalls Ramipril 10mg capsules due to active pharmaceutical ingredient sourced from an unapproved vendor. This may pose a contamination risk. Consumers should check product details and contact Lupin for guidance.
Lupin Pharmaceuticals recalls Cefixime oral suspension (100mg/5mL) due to potential subpotency from stability testing. This may affect medication effectiveness. Contact for return instructions.
Lup: Cefixime oral suspension (200mg/5mL) with failed content uniformity specifications. Recalled due to potential inconsistent drug levels. No remedy stated in official notice.
Lupin Pharmaceuticals recalls Cefdinir oral suspension 250mg/5mL (60mL bottle) due to container seal failure. Rx-only medication may leak or contaminate. Contact for return instructions.
Lupin Pharmaceuticals recalls Cefdinir oral suspension (125 mg/5 mL) for foreign material in reconstituted bottles. This medication is prescription-only and may cause issues if used after reconstitution.
Lupin Pharmaceuticals recalls Cefdinir oral suspension (250 mg/5 mL) due to foreign material complaints in reconstituted bottles. This medication is prescription-only and sold in 60mL bottles.
Lupin Pharmaceuticals recalls 300mg Rifampin Capsules USP 30-count bottles due to subpotent drug content. This may not provide intended treatment. Contact for details.
Lupin Pharmaceuticals recalls Voriconazole oral suspension (40mg/mL, orange-flavored) due to missing package insert. This may affect safe use of the medication. Check product details and contact Lupin for instructions.
Lupin Pharmaceuticals recalls 30-count Rifampin Capsules USP 30: subpotent drug and failed impurities may not work as intended. Contact for return instructions.
Lupin Pharmaceuticals recalls 150mg Rifampin Capsules (30-count) due to subpotent drug and failed impurities. Rx-only product with specific batch numbers. Contact for return instructions.
Lupin Pharmaceuticals recalls 100mg/5mL oral suspension bottles due to failed impurities and degradation specifications. This prescription drug may pose safety risks if used as intended.
Lupin Pharmaceuticals recalls 5mg desloratadine tablets (NDC 68180-153-01/02) due to N-Nitroso desloratadine impurity exceeding safe limits. Rx-only products with specific lot numbers and expiration dates.
Lupin Pharmaceuticals recalls 250mg penicillamine tablets (Rx only) due to failed dissolution specifications. This may affect medication effectiveness. Contact for return instructions.
Lupin Pharmaceuticals recalls 10mg Amlodipine Besylate tablets due to subpotent drug levels. Affected lots may not provide intended medication strength. No remedy specified in official notice.
Lupin Pharmaceuticals recalls Tydemy tablets due to stability and impurity failures. Affected lots may have inactive content and impurities that could pose risks. Contact for details.
Lupin Pharmaceuticals recalls 0.05% clobetasol propionate cream tubes due to low drug potency observed in stability testing. Affected lots may not provide intended treatment.
Lupin Pharmaceuticals recalls 300mg Rifampin capsules due to impurities detected during long-term stability testing. This may affect safety if stored beyond expiration.
Lupin Pharmaceuticals recalls 40mg Quinapril tablets due to detected N-Nitroso impurity exceeding safe limits. Affected lots from 2022-2024 may pose health risks. Consumers should contact for details.
Lupin Pharmaceuticals recalls 20mg Quinapril tablets due to N-Nitroso impurity exceeding safety limits. Affected lots may pose health risks. Contact for return instructions.
Lupin Pharmaceuticals recalls 10 mg Lisinopril tablets with a metal piece embedded in one tablet. This could cause injury if swallowed. Consumers should contact the company for details.
Lupin Pharmaceuticals recalls 600mg Zileuton Extended-Release Tablets due to failed dissolution testing. Rx-only medication with specific batch numbers and expiration dates. Consumers should contact manufacturer for details.
Lupin Pharmaceuticals recalls GaviLyte -C oral solution with failed stability specification. This may affect safety and requires checking product details.
Lupin Pharmaceuticals recalls 50mg/12.5mg Losartan Potassium and Hydrochlorothiazide Tablets due to AZIDO impurity levels above acceptable limits. Rx-only bottles with specific NDC numbers and production dates are affected.
Lupin Pharmaceuticals recalls 25mg Losartan Potassium Tablets with AZIDO impurities above safe limits. Stop using affected bottles to avoid potential health risks.
Lupin Pharmaceuticals recalls 30-count and 90-count Losartan Potassium and Hydrochlorothiazide Tablets (100 mg/25 mg) with AZIDO impurities above acceptable limits. Rx only, manufactured in India with US distribution.
Lupin Pharmaceuticals recalls 100mg/12.5mg Losartan Potassium and Hydrochlorothiazide Tablets due to AZIDO impurity levels above acceptable limits. Rx-only bottles with specific NDC numbers and lots are affected.
Lupin Pharmaceuticals recalls 50mg Losartan Potassium Tablets with AZIDO impurities above safe limits. Rx-only medication from India manufactured for US distribution.
Lupin Pharmaceuticals recalls 100mg Losartan Potassium Tablets with AZIDO impurities above safe levels. Stop using affected bottles to avoid potential health risks.
Lupin Pharmaceuticals recalls 5mg oxycodone tablets due to impurity detected at 18-month stability test. This may pose safety risks if stored beyond expiration.
Lupin Pharmaceuticals recalls Gatifloxacin Ophthalmic Solution 0.5% 2.5mL bottles due to stability issues that could alter drug concentration. This Rx-only medication was manufactured in India with specific lot numbers and expiration dates.
Lupin Pharmaceuticals recalls Tydemy birth control tablets due to subpotent drug levels. Affected lots expire May 2022. Stop using immediately to avoid potential ineffective contraception.
Lupin Pharmaceuticals recalls Gatifloxacin Ophthalmic Solution 0.5% 2.5mL bottles due to stability issues that could alter drug concentration. Rx only product manufactured in India with specific lot and expiration.
Lupin Pharmaceuticals recalls 150/12.5 mg irbesartan and hydrochlorothiazide tablets with impurity N-nitrosoirbesartan detected in API. Affected lots expire through April 2022.
Lupin Pharmaceuticals recalls 150mg Irbesartan Tablets (NDC 68180-411-06/09) due to impurity N-nitrosoirbesartan detected in the active ingredient. Rx only products with specific lot numbers and expiration dates are affected.
Lupin Pharmaceuticals recalls specific lots of Irbesartan and Hydrochlorothiazide tablets due to detected impurity N-nitrosoirbesartan in the manufacturing process.
Lupin Pharmaceuticals recalls 125mg Imipramine Pamoate Capsules due to dissolution test failure at 9 months. This may affect drug stability. Check NDC# 68180-316-06 and lot H002205.
